湖岸生物上涨4.76%，报0.977美元/股，总市值4026.07万美元

Core Insights - Lakeshore Biosciences (LSB) experienced a stock price increase of 4.76%, reaching $0.977 per share, with a total market capitalization of $40.26 million as of July 29 [1] - For the fiscal year ending September 30, 2024, Lakeshore Biosciences reported total revenue of 372 million RMB, reflecting a year-on-year growth of 36.2% [1] - The company achieved a net profit attributable to shareholders of 20.58 million RMB, marking a significant year-on-year increase of 111.79% [1] Company Overview - Lakeshore Biosciences is a Cayman Islands-registered holding company, primarily operated by its domestic subsidiary, Beijing Yisheng Biotechnology Co., Ltd. [1] - Beijing Yisheng Biotechnology Co., Ltd. is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer [1]